Novel Inhibitors of Advanced Glycation Endproducts
- 1 September 1999
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 262 (3) , 651-656
- https://doi.org/10.1006/bbrc.1999.1275
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathyProceedings of the National Academy of Sciences, 1997
- Diabetic late complications: Will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?Journal of Diabetes and its Complications, 1995
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Lipid advanced glycosylation: pathway for lipid oxidation in vivo.Proceedings of the National Academy of Sciences, 1993
- Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan chargeKidney International, 1993
- Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and AgingPublished by Elsevier ,1992
- Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression.Proceedings of the National Academy of Sciences, 1984
- Studies of an unusual hemoglobin in patients with diabetes mellitusBiochemical and Biophysical Research Communications, 1969
- An abnormal hemoglobin in red cells of diabeticsClinica Chimica Acta; International Journal of Clinical Chemistry, 1968